story of the week
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
J. Clin. Oncol 2020 Oct 13;[EPub Ahead of Print], KT Flaherty, RJ Gray, AP Chen, S Li, LM McShane, D Patton, SR Hamilton, PM Williams, AJ Iafrate, J Sklar, EP Mitchell, LN Harris, N Takebe, DJ Sims, B Coffey, T Fu, M Routbort, JA Zwiebel, LV Rubinstein, RF Little, CL Arteaga, R Comis, JS Abrams, PJ O'Dwyer, BA ConleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.